https://www.PR.com/ Latest news releases from PR.com for Cayman Chemical Company. Tue, 06 Oct 2026 08:49:58 -0400 © 2026 PR.com 60 en-us https://www.PR.com/images/logo_white.jpg https://www.PR.com/ 68 69 PR.com provides press release distribution, and is a unique directory of businesses, products and services. Find full company profiles. https://www.pr.com/press-release/945619 Fri, 15 Aug 2025 16:12:43 -0400 The Cayman Biomedical Research Institute (CABRI) has announced that applications are now open for their undergraduate research fellowships. Applications may be submitted on the CABRI website from August 11, 2025 through September 29, 2025. [PR.com] https://www.pr.com/press-release/945619 Cayman Chemical Company https://www.pr.com/press-release/913281 Fri, 07 Jun 2024 03:00:00 -0400 Cayman Chemical, a leading supplier of research tools for the life science community, has widened their portfolio to include molecular-based detection kits through a strategic partnership with PCRassays.com. PCRassays.com offers more than 200 qPCR-based assays for infectious diseases, over 50 of which are multiplex assays, including panels for wound, upper respiratory, urinary tract, and STIs. “We are delighted to [PR.com] https://www.pr.com/press-release/913281 Cayman Chemical Company https://www.pr.com/press-release/906529 Thu, 22 Feb 2024 03:00:00 -0500 Cayman Chemical introduces the latest addition to the company’s portfolio of lipid nanoparticle (LNP) research tools for academic, pharma, and biotech researchers worldwide. The LipidLaunch™ product line helps researchers pursue LNPs for the delivery of nucleic acid therapies in untold health applications, ranging from vaccine development to cancer and cell or gene therapies. [PR.com] https://www.pr.com/press-release/906529 Cayman Chemical Company https://www.pr.com/press-release/896925 Wed, 04 Oct 2023 17:37:30 -0400 Cayman LipiDOT Strips™ are a simple tool for the rapid identification of protein-lipid interactions. Researchers can screen a protein of interest against 22 biologically relevant lipids in one assay in a single day at a lower price compared with existing commercial options. [PR.com] https://www.pr.com/press-release/896925 Cayman Chemical Company https://www.pr.com/press-release/891103 Thu, 13 Jul 2023 03:00:00 -0400 Cayman and Navinci have partnered to bring next-generation proximity ligation-based solutions for spatial proteomics to US and Canada-based researchers. [PR.com] https://www.pr.com/press-release/891103 Cayman Chemical Company https://www.pr.com/press-release/885614 Sun, 30 Apr 2023 11:41:03 -0400 Cayman Chemical and the Centers for Disease Control and Prevention (CDC) have released a new addition to the Traceable Opioid Material® Kits (TOM Kits®) product line that expands testing laboratory capabilities beyond synthetic opioids to include additional emerging drugs of abuse that are commonly found as co-drugs in fentanyl-containing samples. [PR.com] https://www.pr.com/press-release/885614 Cayman Chemical Company https://www.pr.com/press-release/867943 Fri, 26 Aug 2022 11:01:54 -0400 The Cayman Biomedical Research Institute (CABRI) is offering research grants in amounts up to $100,000 to support essential research on specialized pro-resolving mediator (SPM) analytical methods. [PR.com] https://www.pr.com/press-release/867943 Cayman Chemical Company https://www.pr.com/press-release/867940 Fri, 26 Aug 2022 11:01:00 -0400 The Cayman Biomedical Research Institute (CABRI) is accepting applications from undergraduate students who have been offered an unpaid laboratory research position under an accredited principal investigator. Applications will be accepted from August 22 until September 18, 2022. [PR.com] https://www.pr.com/press-release/867940 Cayman Chemical Company https://www.pr.com/press-release/845019 Sun, 19 Sep 2021 03:00:00 -0400 The National Institute of Dental and Craniofacial Research has awarded Cayman Chemical with a $1,700,500 grant to explore Cayman’s patented small molecule bone repair agent KMN-159 as the active pharmaceutical ingredient (API) in a drug-device combination to improve the mechanical anchorage of dental titanium implants into the jawbone. The studies proposed in this grant aim to address several clinical challenges for [PR.com] https://www.pr.com/press-release/845019 Cayman Chemical Company https://www.pr.com/press-release/836572 Sun, 16 May 2021 03:00:00 -0400 Cayman Chemical's new Q-Plex™ Autoantibody Detection 10-Plex Panel, developed in collaboration with Quansys Biosciences, offers standardized, multiplex capabilities for the concurrent analysis of ten prominent analytes associated with rheumatoid arthritis or other autoimmune diseases. This new qualitative, chemiluminescent ELISA measures human antibodies against PAD3, PAD4, fibrinogen, citrullinated fibrinogen, [PR.com] https://www.pr.com/press-release/836572 Cayman Chemical Company https://www.pr.com/press-release/830624 Wed, 10 Feb 2021 03:00:00 -0500 Cayman Chemical’s complete assay kit, protein, antibody, and biochemical portfolio is now more accessible to Denmark, Finland, Iceland, Norway, Sweden, and the Baltic countries as well as Russia through a distribution agreement with Nordic BioSite. Headquartered in Täby, Sweden, Nordic BioSite’s sales and technical support teams operate with a "By Your Side" mission to assist customers in [PR.com] https://www.pr.com/press-release/830624 Cayman Chemical Company https://www.pr.com/press-release/824848 Sat, 07 Nov 2020 03:00:00 -0500 Cayman held a groundbreaking ceremony to start the buildout of a $20 million research and development facility at its headquarters in Ann Arbor, MI. [PR.com] https://www.pr.com/press-release/824848 Cayman Chemical Company https://www.pr.com/press-release/822961 Sat, 10 Oct 2020 03:00:00 -0400 The National Institute on Aging (NIA) has awarded Cayman Chemical with a Phase II Small Business Innovation Research (SBIR) grant to develop an assay platform and novel antibodies to support the treatment, prevention, and early diagnosis of Alzheimer’s disease and other tauopathies. [PR.com] https://www.pr.com/press-release/822961 Cayman Chemical Company https://www.pr.com/press-release/819251 Wed, 19 Aug 2020 03:00:00 -0400 Cayman Biomedical Research Institute (CABRI) is now accepting applications from undergraduate students who have been offered an unpaid laboratory research position under an accredited principal investigator. Applications will be accepted until September 20, 2020, for awards to be distributed by November 2, 2020. Grants range from $2,000 - $5,000 and may be awarded as individual or group grants. [PR.com] https://www.pr.com/press-release/819251 Cayman Chemical Company https://www.pr.com/press-release/819037 Sat, 15 Aug 2020 03:00:00 -0400 Cayman and GenScript have come together to create a complete package of neoantigen discovery services. Through combined efforts, MHC-associated peptides are identified and verified as immunogenic to guide peptide synthesis for vaccine development. “Cayman provides a complete workflow enabling the identification of peptide sequences as putative neoantigens. We are excited to add GenScript’s technical means and [PR.com] https://www.pr.com/press-release/819037 Cayman Chemical Company https://www.pr.com/press-release/815879 Wed, 01 Jul 2020 03:00:00 -0400 Each year during Women’s History Month, Cayman provides travel grants to help women researchers attend conferences to benefit from and contribute to the larger scientific community. This year, because the COVID-19 pandemic caused most conferences to cancel or postpone and many academic labs to close, Cayman introduced a new program to help support women in research. A record high of forty women will benefit from [PR.com] https://www.pr.com/press-release/815879 Cayman Chemical Company https://www.pr.com/press-release/807785 Thu, 12 Mar 2020 03:00:00 -0400 In its ongoing commitment to funding research for new treatments for rare diseases, Cayman Biomedical Research Institute (CABRI) has announced its principle investigator and undergraduate awardees for the 2020 academic year. “We are excited to support these scientists actively researching treatments for often poorly funded diseases,” said Stephen Barrett, Director on the board of CABRI and Vice President of [PR.com] https://www.pr.com/press-release/807785 Cayman Chemical Company https://www.pr.com/press-release/795324 Wed, 25 Sep 2019 03:00:00 -0400 The NIH’s National Institute of Arthritis and Musculoskeletal & Skin Diseases (NIAMS) has awarded Cayman Chemical with a Phase II Small Business Innovation Research (SBIR) grant to develop its patented small molecule bone repair agent KMN-159. [PR.com] https://www.pr.com/press-release/795324 Cayman Chemical Company https://www.pr.com/press-release/793690 Thu, 05 Sep 2019 03:00:00 -0400 Biosynthetic Technologies (BT) today announced it has signed on with Cayman Chemical for the production and distribution of novel Estolide compounds for pharmaceutical testing applications. BT is excited to partner with Cayman Chemical to provide discovery and pre-clinical development services to the global pharmaceutical, biotechnology, and academic research markets using Estolide products (also known as fatty acid [PR.com] https://www.pr.com/press-release/793690 Cayman Chemical Company https://www.pr.com/press-release/787970 Sat, 22 Jun 2019 03:00:00 -0400 Cayman now offers multiplex immunoassay technology powered by Quansys Biosciences. This line of fully quantitative Q-Plex™ multiplex ELISAs and chemiluminescent Q-View™ imagers provides a highly sensitive means to simultaneously measure multiple markers using a single sample. “Adding the Q-Plex™ arrays and Q-View™ imagers to our portfolio gives our customers access to an innovative multiplex [PR.com] https://www.pr.com/press-release/787970 Cayman Chemical Company https://www.pr.com/press-release/786523 Wed, 05 Jun 2019 03:00:00 -0400 Cayman Chemical, an industry-leading supplier of bioactive lipids, analytical standards, and contract lipidomic services, announced today that it has acquired Matreya, LLC, a lipid biochemical company located in State College, Pennsylvania, with strengths in synthesis, extraction, and purification of natural products. Matreya stocks a wide selection of high-purity sphingolipids, phospholipids, fatty acids and esters, and [PR.com] https://www.pr.com/press-release/786523 Cayman Chemical Company https://www.pr.com/press-release/759917 Sat, 21 Jul 2018 03:00:00 -0400 Cayman has increased its financial support of the LIPID MAPS® Lipidomics Gateway. The newly launched LIPID MAPS® website (June 2018) provides easy access to free tools and resources, including a searchable lipid structure database (with over 43,000 entries), mass spectrometry spectra prediction tools, lipid structure drawing tools, experimental protocols, systems biology pathway maps, statistical analysis tools, and a [PR.com] https://www.pr.com/press-release/759917 Cayman Chemical Company https://www.pr.com/press-release/758080 Fri, 20 Jul 2018 00:24:28 -0400 Sensitive and direct measurement of cGAMP levels in cell lysates is now possible with Cayman’s much-anticipated 2’3’-cGAMP ELISA Kit. Developed by Cayman scientists, in conjunction with expert nucleotide scientists at Biolog Life Science Institute in Germany, this competitive assay offers key improvements from the previous methods used to quantify 2’3’-cGAMP content. The assay has a large [PR.com] https://www.pr.com/press-release/758080 Cayman Chemical Company https://www.pr.com/press-release/750945 Wed, 18 Apr 2018 03:00:00 -0400 Cayman Chemical has launched a new line of ready-to-use, quantitative lipid standards prepared specifically for mass spectrometry applications. This new line of MaxSpec™ analytical standards complements Cayman’s high-purity, basic research tools that researchers have been using for more than 37 years. All MaxSpec™ standards are provided in solution and formulated to save time when preparing standards and [PR.com] https://www.pr.com/press-release/750945 Cayman Chemical Company https://www.pr.com/press-release/738851 Thu, 14 Dec 2017 03:00:00 -0500 A presentation at the Southwestern Association of Toxicologists November 2017 scientific meeting in San Antonio, Texas highlighted the utility of Cayman’s Synthetic Cannabinoid Screening Library. This library is comprised of more than 350 synthetic cannabinoid standards, including parent compounds and their positional isomers, analogs, and homologs. At the meeting, Amanda Moore, MSFS, Michael Frontz, MSFS, [PR.com] https://www.pr.com/press-release/738851 Cayman Chemical Company https://www.pr.com/press-release/729909 Sat, 16 Sep 2017 03:00:00 -0400 Cayman Chemical is collaborating with ThermoFisher and HighChem to provide accurate and high quality tandem spectra to the mzCloud™ library of mass data. mzCloud™ is a web-based mass spectral database comprised of a curated collection of high- and low-resolution MSn spectra acquired from small molecules under a number of experimental conditions. As a freely searchable database, this interface presents a robust [PR.com] https://www.pr.com/press-release/729909 Cayman Chemical Company https://www.pr.com/press-release/724387 Wed, 26 Jul 2017 03:00:00 -0400 Cayman Chemical is distributing the new InCellis® Smart Cell Imaging System from Bertin Technologies. The InCellis® is the first all-in-one cell imager developed to generate publication-quality images and time-lapse videos of cells on tissue slides or in cell culture. Multichannel fluorescence, phase contrast, and brightfield imaging can be easily performed by all biologists on the bench without the need for long, [PR.com] https://www.pr.com/press-release/724387 Cayman Chemical Company https://www.pr.com/press-release/721030 Fri, 23 Jun 2017 08:23:00 -0400 Cayman Chemical, in collaboration with PinPoint Testing, LLC and Biotage, has introduced the ToxBox® THC/THC Metabolite Pack, an all-inclusive tool to detect THC, the primary active constituent in Cannabis, and its main metabolites. ToxBox®, a proprietary brand of products by PinPoint Testing, is a high-throughput solution for detecting multiple analytes in biological samples. The ToxBox® THC/THC Metabolite [PR.com] https://www.pr.com/press-release/721030 Cayman Chemical Company https://www.pr.com/press-release/719655 Wed, 14 Jun 2017 03:00:00 -0400 Cayman has released Phytocannabinoid Mixture 10 (CRM), a quantitative, multi-analyte mixture for use as an analytical standard in the simultaneous detection of the ten most prevalent phytocannabinoids found in Cannabis plants. [PR.com] https://www.pr.com/press-release/719655 Cayman Chemical Company https://www.pr.com/press-release/713879 Wed, 26 Apr 2017 03:00:00 -0400 Cayman Chemical, in collaboration with BMG LABTECH GmbH, has developed a novel assay kit to measure mitochondrial function under a dynamic range of oxygen concentrations. The Mito Stress Test (ACU Format) is designed to measure oxygen consumption rate (OCR) and extracellular acidification (ECA) simultaneously and in real time under tightly controlled atmospheric conditions using open-flow respirometry. The assay was [PR.com] https://www.pr.com/press-release/713879 Cayman Chemical Company https://www.pr.com/press-release/666862 Thu, 14 Apr 2016 03:00:00 -0400 BreviTest Technologies has been awarded a $234,412 grant from the National Institute on Drug Abuse of the National Institutes of Health (NIH) to explore rapid testing for THC, the main active ingredient in cannabis. The federal funds, awarded under the NIH’s Small Business Innovation Research program, will be used to develop BreviTest’s rapid robotic analyzer into a curbside saliva test of cannabis [PR.com] https://www.pr.com/press-release/666862 Cayman Chemical Company https://www.pr.com/press-release/637621 Thu, 17 Sep 2015 03:00:00 -0400 The University of Texas MD Anderson Cancer Center, Cayman Chemical and Fannin Innovation Studio have formed ACF Pharmaceuticals, LLC. The pre-clinical therapeutics company is dedicated to discovering and developing novel small molecule inhibitors for the treatment of a variety of inflammation-induced cancers, including melanoma and colon and pancreatic cancer. Chronic inflammation has long been associated with cancer [PR.com] https://www.pr.com/press-release/637621 Cayman Chemical Company https://www.pr.com/press-release/636561 Thu, 10 Sep 2015 03:00:00 -0400 The United States Patent and Trademark Office has issued a patent to Cayman Chemical and the University of Michigan claiming detection analyte probes based on a natural product mimic of the methyltransferase cofactor S-adenosylmethionine (SAM). Aptly named SAM-Screener™, these probes are the foundation of Cayman’s high-throughput, one-step florescent binding assays for identification of SAM-competitive [PR.com] https://www.pr.com/press-release/636561 Cayman Chemical Company